Study Comparing Continuous Subcutaneous Infusion Of ABBV-951 With Oral Carbidopa/Levodopa Tablets For Treatment Of Motor Fluctuations In Adult Participants With Advanced Parkinson's Disease Study Comparing Continuous Subcutaneous Infusion Of ABBV-951 With Oral Carbidopa/Levodopa Tablets Fo ...
A Randomized, Double-Blind, Double-Dummy, Active-Controlled Study Comparing the Efficacy, Safety and Tolerability of ABBV-951 to Oral Carbidopa/Levodopa in Advanced Parkinson's Disease Patients A Randomized, Double-Blind, Double-Dummy, Active-Controlled Study Comparing the Efficacy, Safety and ...
Parkinson's Disease (PD)
Drug: ABBV-951;Drug: Placebo for Levodopa/Carbidopa(LD/CD);Drug: Levodopa/Carbidopa(LD/CD);Drug: Placebo for ABBV-951 Drug: ABBV-951;Drug: Placebo for Levodopa/Carbidopa(LD/CD);Drug: Levodopa/Carbidopa(LD/CD);Drug: P ...
A Pharmacokinetic Study of ND0612 Delivered as a Continuous Subcutaneous in Parkinson's Disease Patients A Pharmacokinetic Study of ND0612 Delivered as a Continuous Subcutaneous in Parkinson's Disease Pati ...
A Phase I/II Pharmacokinetic (PK) Study of ND0612, a Liquid Formulation of Levodopa/Carbidopa(LD/CD), Delivered as a Continuous Subcutaneous in Parkinson's Disease (PD) Patients Treated With LD A Phase I/II Pharmacokinetic (PK) Study of ND0612, a Liquid Formulation of Levodopa/Carbidopa(LD/CD ...
Parkinson's Disease
Drug: Levodopa and carbidopa SC solution;Drug: Oral levodopa and carbidopa
NeuroDerm Ltd.
Michael J. Fox Foundation for Parkinson's Research